Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial (ARTIST-II)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Samsung Medical Center
Information provided by (Responsible Party):
Won Ki Kang, Samsung Medical Center Identifier:
First received: January 3, 2013
Last updated: April 30, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)